HALOZYME HYPERCON
LIVE

Serial Number

99501527

Owner

Halozyme, Inc.

Attorney

Gene K. Park

Filing Date

Nov 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

HALOZYME HYPERCON Trademark

Serial Number: 99501527

HALOZYME HYPERCON is a trademark filed by Halozyme, Inc. on November 17, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Halozyme, Inc. (3 trademarks)

12390 El Camino Real
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

November 17, 2025

Registration Date

Not Registered

Goods & Services

Research and development in the field of pharmaceuticals and drug delivery; scientific and medical research, namely, conducting clinical trials for others; Scientific research and design and development, namely, product design and development in the field of excipients and formulations for use with therapeutic biologics; Scientific research and design, namely product design and development in the field of therapeutic formulation development; Consulting in the fields of product design and development in the field of therapeutic formulation and excipient development; Chemical engineering in the nature of formulation and reformulation of therapeutic compositions; Development of new technology for others in the field of biomaterials, biotechnology and nanotechnology

Custom manufacture of reformulated pharmaceuticals for easier patient delivery; Custom manufacturing, processing, and treating the therapeutic molecules of others; Biomanufacturing for others, namely, manufacturing therapeutic molecules of others using biological organisms in the manufacturing process; Custom manufacture of reformulated pharmaceuticals and therapeutics

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 1, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 1, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 2, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 2, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 2, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Nov 17, 2025 MAFR
NEW APPLICATION ENTERED
Nov 17, 2025 NWAP